Skip to content

Bio-Rad Laboratories BIO Other income, net (Note 6)

Other income, net (Note 6) at other companies

Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$86M+339%
Abbott logo
AbbottABT
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
Danaher logo
DanaherDHR
Agilent Technologies logo
Agilent TechnologiesA
TEC
Bio-TechneTECH

Other financials

Income statement

See full
Revenue$592.1M+1.1%
Gross profit$309.4M+1.1%
Operating income$34.1M+43.9%
Net income-$527.1M-924%
EPS (diluted)-$19.55-954%

Balance sheet

See full
Cash & equivalents$509.0M-2.7%
Total debt$987.3M-28.4%
Total equity$6.9B+2.6%
Total assets$9.8B+2.8%

Cash flow

See full
Operating cash flow$108.1M-16.8%
CapEx$30.0M-12.8%
Free cash flow$78.1M-18.2%

Valuation

See full
Market cap$7.56B+10.3%
Enterprise value$8.04B+4.2%
P/E44.8×
P/S2.9×+0.2×

Profitability

See full
Gross margin51.9%-1.6pp
Operating margin8.8%-3.1pp
Net margin6.5%+3.4pp
FCF margin13.8%-0.2pp

Returns & leverage

See full
Return on equity2.5%+1.3pp
Debt / equity0.1×-0.1×
Current ratio3.2×-2.8×

Where this comes from

Reported directly by Bio-Rad Laboratories in its filing.

Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.

The official record: Bio-Rad Laboratories’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bio-Rad Laboratories's other income, net (note 6).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bio-Rad Laboratories's other income, net (note 6)?
Bio-Rad Laboratories (BIO) reported other income, net (note 6) of $24.2M in Q1 2026.
How has Bio-Rad Laboratories's other income, net (note 6) changed year-over-year?
Bio-Rad Laboratories's other income, net (note 6) decreased by 34.9% year-over-year, from $37.2M to $24.2M.
What is the long-term trend for Bio-Rad Laboratories's other income, net (note 6)?
Over 4 years (2021 to 2025), Bio-Rad Laboratories's other income, net (note 6) has grown at a 35.5% compound annual growth rate (CAGR), from $26.78M to $90.3M.